CAR-T Cell Therapy Resource Center
News & Information for Healthcare Professionals
CAR-T Cell Therapy HCP Guide – KTE-C19 Studies – Zuma 3 & 4 Trials
CAR T-Cell Therapy for ALL
Axicabtagene ciloleucel (KTE-C19) is also being investigated in the ZUMA-3 and ZUMA-4 trials for treatment of relapsed/refractory acute lymphoblastic leukemia...
CAR-T Cell Therapy HCP Guide – KTE-C19 Studies – Zuma 2 Trials
ZUMA-2 Trial: Mantle Cell Lymphoma
In the ZUMA-2 trial, Kite Pharma is also evaluating the treatment of relapsed/refractory mantle cell lymphoma (MCL) with KTE-C19. MCL...
CAR-T Cell Therapy HCP Guide – KTE-C19 Studies – Zuma 1 Trials
Hematologic Cancers: On Deck for CAR T
Emerging immunotherapies such as chimeric antigen receptor (CAR) T-cell therapies are some of the most exciting new investigational...
StatPearls Question of the Week – #3
From the early clinical trials involving chimeric antigen receptor T cell therapy (CAR-T), cytokine release syndrome has been a major problem. To block the...
Why Does Immunotherapy Work in Some Patients but not in Others?
April 21, 2017 (Medical News Today)
André Veillette and a team of researchers at the Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical...
Advances in Treating Sarcoma with Immunotherapy
January 19, 2017 (Discovery Medicine)
Sarcomas are rare and aggressive malignancies of bone and soft tissue affecting all ages of patients that are usually incurable...
CAR-T Cell Therapy HCP Guide – Mechanism of Action
CAR T-Cell Therapy: How It Works
Chimeric antigen receptor (CAR) T-cell therapy is an investigational form of immunotherapy -- in fact, the first gene therapy...
VIDEO: Dr. Steven Rosenberg on saving lives with Car T Therapy
December 17, 2015 (Leukemia & Lymphoma Society)
Dr. Steven Rosenberg explains why immunotherapies provides the best clues for cancer treatments for patients who can’t be...
StatPearls Question of the Week #2
What is the most common adverse effect of chimeric antigen receptor therapy (CAR-T)?
A. Reactivation of tuberculosis
B. Stevens-Johnson syndrome
C. Cytokine release...
Implanted scaffold with T cells rapidly shrinks tumors
April 26, 2017 (Medical News Today)
Cellular therapy hasn't had much success in fighting solid tumors, partly because it's been difficult to deliver anti-cancer T...
